Market Place
Sourcing Support
Grifols Receives FDA Approval for Pediatric Bleeding Treatment
29 Oct 2024 //
GLOBENEWSWIRE
Grifols Partners With BARDA For Ocular Immunoglobulin Testing
22 Oct 2024 //
GLOBENEWSWIRE
GigaGen garners up to $135M BARDA bucks to beat botulism
03 Oct 2024 //
FIERCE BIOTECH
Grifols Plans $402M Investment In New Industrial Centre
30 Sep 2024 //
REUTERS
Grifols minority shareholders team up to ask for a board seat
20 Sep 2024 //
REUTERS
Grifols Receives Expanded XEMBIFY® Label In U.S. For IG Portfolio
29 Jul 2024 //
GLOBENEWSWIRE
Grifols Gets $6B Takeover Offer from Founding Family, Brookfield to Go Private
08 Jul 2024 //
BIOSPACE
Spanish drugmaker Grifols appoints new finance chief as shake-up continues
04 Jul 2024 //
REUTERS
Unit of Grifols shareholder Scranton reaches debt refinancing deal
03 Jul 2024 //
REUTERS
Grifols` Biotest Projects $1B US Sales Of Yimmugo Over 7 Years
01 Jul 2024 //
GLOBENEWSWIRE
Grifols Completes Sale Of 20% Stake In SRAAS And Forms Alliance With Haier Group
18 Jun 2024 //
GLOBENEWSWIRE
Grifols Receives FDA Approval For Yimmugo® To Treat Primary Immunodeficiencies
17 Jun 2024 //
GLOBENEWSWIRE
Grifols Partnership has received four CDMO Leadership Awards in 2024
24 May 2024 //
PRESS RELEASE
Inc Medical Industries Partnership with Grifols for Enhanced Medication Safety
08 Apr 2024 //
PR NEWSWIRE
Grifols Procleix ArboPlex Assay® Receives CE Mark
04 Apr 2024 //
GLOBENEWSWIRE
Shares in Spanish drugmaker Grifols tumble on Fitch, S&P downgrades
14 Mar 2024 //
REUTERS
Grifols says due diligence done, Shanghai RAAS stake sale to go ahead
01 Mar 2024 //
REUTERS
Spanish supervisor analysing new information from Grifols
27 Feb 2024 //
REUTERS
Grifols appoints new CEO Nacho Abia to the board
26 Feb 2024 //
REUTERS
Grifols preps blood clot treatment approval push after ph. 3 win
15 Feb 2024 //
FIERCE PHARMA
Spain`s Grifols hires new CEO weeks after damaging short-seller report
05 Feb 2024 //
REUTERS
Grifols files lawsuit against hedge fund for making `false and misleading statements`
30 Jan 2024 //
FIERCE PHARMA
Spain`s Grifols sues Gotham City fund, JV over damaging report
26 Jan 2024 //
REUTERS
ECB sounds out lenders on exposure to Spanish drugmaker Grifols - sources
17 Jan 2024 //
REUTERS
Grifols says Haier Group still OK to buy stake in Shanghai RAAS
14 Jan 2024 //
REUTERS
Grifols shares suffer worst week on record after short-seller report
12 Jan 2024 //
REUTERS
Spain`s Grifols to sue short-seller over critical report, shares jump
10 Jan 2024 //
REUTERS
Grifols accused of manipulating finances by short seller Gotham City
09 Jan 2024 //
ENDPTS
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%
15 Nov 2023 //
GLOBENEWSWIRE
Grifols shares soar after 2023 profit outlook upgrade
02 Nov 2023 //
REUTERS
Araclon vaccine appears to slow Alzheimer`s in phase 2 analysis
26 Oct 2023 //
FIERCE BIOTECH
Araclon Presents Positive Final Results from Phase 2 Clinical Study of ABvac40
24 Oct 2023 //
GLOBENEWSWIRE
AIS Healthcare’s Infusion Care Announces Joint Study with Grifols
23 Oct 2023 //
BUSINESSWIRE
Grifols Accelerates Healthcare Innovation with Google Cloud™s AI and Analytics
01 Aug 2023 //
GLOBENEWSWIRE
Grifols Partners with Google Cloud to Advance Drug Development
01 Aug 2023 //
CONTRACT PHARMA
Grifols Achieves Positive Topline Results From Phase 4 Study of XEMBIFY
20 Jul 2023 //
GLOBENEWSWIRE
Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein
18 Jul 2023 //
GLOBENEWSWIRE
Grifols Meets Enrollment Target in PIII of Two Dose Regimens of Prolastin®-C
13 Jul 2023 //
GLOBENEWSWIRE
Astellas president jumps to a new Frontier; Grifols chairman named CEO
12 May 2023 //
ENDPTS
Grifols Launches AlphaID At Home, Enabling U.S. Consumers to Self-Screen
11 May 2023 //
GLOBENEWSWIRE
Grifols lifts 2023 margin outlook as revenue rises
09 May 2023 //
REUTERS
Spain`s Grifols names current chairman as CEO, ending family leadership
08 May 2023 //
REUTERS
Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023
18 Apr 2023 //
PR NEWSWIRE
Selagine Enters into a Collaborative Agreement with Grifols
06 Mar 2023 //
PR NEWSWIRE
Grifols` shares tank 10% as 2023 outlook disappoints
28 Feb 2023 //
REUTERS
Grifols is the latest drugmaker to succumb to the layoff trend
16 Feb 2023 //
FIERCE PHARMA
Grifols receives FDA clearance for AlphaID At Home
03 Nov 2022 //
PRNEWSWIRE
Grifols opens plant, snags NICE nod for Tavlesse
19 Oct 2022 //
FIERCEPHARMA
Grifols in 15-year deal with Canada for plasma-based medicines
08 Oct 2022 //
EXPRESS PHARMA
Victor Grifols Roura decides to retire as Chairperson
03 Oct 2022 //
GRIFOLS
Grifols appoints executive chairman as seeks to speed recovery
03 Oct 2022 //
REUTERS
Grifols enters into agreement with Canadian Blood Services
09 Sep 2022 //
PRNEWSWIRE
Grifols in 15-year deal with Canada for plasma-based medicines
07 Sep 2022 //
REUTERS
Grifols highlights an increase in plasma and underscores innovation
10 Jun 2022 //
PRESS RELEASE
GigaGen Publishes Research on the Potential of its Machine Learning Platform
19 May 2022 //
GLOBENEWSWIRE
Grifols accelerating plasma recovery while enhancing performance
06 May 2022 //
GRIFOLS
Grifols shares soar as plasma collection reaches pre-pandemic levels
06 May 2022 //
NASDAQ
Grifols chosen as one of the best companies to work for in Spain by Forbes
04 May 2022 //
GRIFOLS
Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022
29 Apr 2022 //
PRNEWSWIRE
Grifols completes the acquisition of Biotest: a strategic and transformational
25 Apr 2022 //
PRNEWSWIRE
